Vinay Prasad to head FDA division regulating vaccines
Source: SeekingAlpha
2025-05-06 14:30:15 ET
More on BioNTech, Moderna, etc.
- BioNTech: mRNA Challenges Amid Regulatory Uncertainty (Rating Downgrade)
- BioNTech SE (BNTX) Q1 2025 Earnings Call Transcript
- BioNTech SE 2025 Q1 - Results - Earnings Call Presentation
- Pfizer, GSK RSV shot recommendations under scrutiny from RFK Jr. aide - report
- SA analyst downgrades: COP, ON, BNTX, SKX, ALIZY, SFM
Read the full article on Seeking Alpha
For further details see:
Vinay Prasad to head FDA division regulating vaccines
Novavax Inc.
NASDAQ: NVAX
NVAX Trading
-2.73% G/L:
$10.155 Last:
1,490,860 Volume:
$10.42 Open:
NVAX Latest News
February 26, 2026 08:42:07 pm
Power Hour Surge: Quantum Breakouts, Biotech Visibility, and Crypto Strategy Running into the Close
February 26, 2026 08:00:00 am
Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
NVAX Stock Data
$1,428,366,166
160,874,005
0.11%
93
N/A
Biotechnology & Life Sciences
Healthcare
US
Gaithersburg
